No Detail Found!

Aspartate Aminotransferase-to-Platelet Ratio Index as Predictors of Recompensation in Decompensated Cirrhosis

Author(s)
Dedong Yin Department of Infectious Diseases and Hepatology, The Second Hospital of Shandong University, Jinan, Shandong Province, China
Juanli Wu Department of Infectious Diseases and Hepatology, The Second Hospital of Shandong University, Jinan, Shandong Province, China
Yuying Wang Department of Infectious Diseases and Hepatology, The Second Hospital of Shandong University, Jinan, Shandong Province, China
Xu Liu Department of Infectious Diseases and Hepatology, The Second Hospital of Shandong University, Jinan, Shandong Province, China
Abstract
Objective: To explore the relationship between aspartate aminotransferase-to-platelet ratio index (APRI) level and recompensation in patients with hepatitis B-related decompensated cirrhosis. Study Design: Analytical study. Place and Duration of the Study: The Second Hospital of Shandong University, Jian, China, and Weifang People's Hospital, China, from January 2016 to 2024. Methodology: A total of 166 patients with hepatitis B-related decompensated cirrhosis without antiviral treatment were included. All patients were observed for a minimum of 18 months. The main result is recompensation, de ned as the latest Baveno VII restitution standard. The predictive value of the APRI was assessed by using the receiver operating characteristic (ROC) curves and logistics regression model. Results: In the group with baseline aspartate aminotransferase (AST) d40 U/L, APRI was identi ed as an independent predictor of recompensation in patients with hepatitis B-related decompensated cirrhosis (OR 0.04, 95% CI: 0.002 - 0.686, p = 0.026). For patients treated with nucleos(t)ide analogues (NAs), lower APRI was related to the higher rate of recompensation (OR 0.466, 95% CI: 0.291 - 0.747, p = 0.002). In the baseline AST d40 group and in the data one year after antiviral treatment, the AUROCs for APRI diagnosis of liver cirrhosis were 0.813 and 0.723, respectively. Conclusion: APRI may be used as an independent predictor of recompensation in patients with hepatitis B-related decompensated cirrhosis, particularly in patients undergoing NAs therapy and with low AST levels.
Publication Details
Page(s) 168-173
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 35, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
Chronic hepatitis B, Recompensation, Decompensated liver cirrhosis, Aspartate aminotransferase-to-platelet ratio index
References
Hsu YC,Huang DQ,Nguyen MH .2023 .Global burden of hepatitis B virus: Current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol, 10(8) : 524-37.
Jalan R,D'Amico G,Trebicka J,Moreau R,Angeli P,Arroyo V .2021 .New clinical and pathophysiological perspectives de ning the trajectory of cirrhosis. J Hepatol, 01(Suppl 1) : S14-26.
de Franchis R,Bosch J,Garcia-Tsao G,Reiberger T,Ripoll C .2022 .Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol, 03(1) : 271-74.
Hui VW,Wong GL,Wong VW,Chan HL,Lai JC,Tse YK .2023 .Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis. JHEP Rep, 100814(9) : 100814.
Zhang Y,Liu X,Li S,Lin C,Ye Q,Wang Y .2023 .Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation: A retrospective study based on Baveno VII criteria. doi: 10.1097/ HC9, 8(1) : .
Hofer BS,Simbrunner B,Hartl L,Jachs M,Balcar L,Paternostro R .2023 .Hepatic recompensation according to Baveno VII criteria is linked to a signi cant survival bene t in decompensated alcohol-related cirrhosis. Liver Int, 10(10) : 2220-31.
Hofer BS,Burghart L,Halilbasic E,Simbrunner B,Petrenko O,Mandorfer M .2024 .Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis. Aliment Pharmacol Ther, 10(8) : 962-72.
Wai CT,Greenson JK,Fontana RJ,Kalb eisch JD,Marrero JA,Conjeevaram HS .2003 .A simple noninvasive index can predict both signi cant brosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 50346(2) : 518-26.
Shin WG,Park SH,Jang MK,Hahn TH,Kim JB,Lee MS .2007 .Aspartate aminotransferase to platelet ratio index (APRI) can predict liver brosis in chronic hepatitis B. Dig Liver Dis, 10(4) : 267-74.
Yu ML,Lin SM,Lee CM,Dai CY,Chang WY,Chen SC .2006 .A simple noninvasive index for predicting long-term outcome of chronic hepatitis C after interferon-based therapy. Hepatology, 10(5) : 1086-97.
Lieber CS,Weiss DG,Morgan TR .2006 .Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver brosis. Am J Gastroenterol, 00610(7) : 0241-8.
Wai CT,Cheng CL,Wee A,Dan YY,Chan E,Chua W .2006 .Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int, 01287(6) : 3231-72.
Naveau S,Gaude G,Asnacios A,Agostini H,Abella A,Ova NB .2009 .Diagnostic and prognostic values of noninvasive biomarkers of brosis in patients with alcoholic liver disease. Hepatology, 10(1) : 97-105.
Nunes D,Fleming C,Craven G,Fix D,Heeren O,T O .2009 .Noninvasive markers of liver brosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am J Gastroenterol, 746(6) : 1346-53.
Lee F,Ho C .2022 .Diagnosis and management of chronic hepatitis B: A patient-friendly summary of the 2018 American association for the study of liver diseases practice guidance. Clin Liver Dis (Hoboken), 10(5) : 141-5.
Toghill PJ,Green S,Ferguson F .1977 .Platelet dynamics in chronic liver disease with special reference to the role of the spleen. J Clin Pathol, 10(4) : 367-71.
Aster RH .1966 .Pooling of platelets in the spleen: Role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest, 10(5) : 645-57.
McCormick PA,Murphy KM .2000 .Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Baillieres Best Pract Res Clin Gastroenterol, 0144(6) : 1009-31.
Adinol LE,Giordano MG,Andreana A,Tripodi MF,Utili R,Cesaro G .2001 .Hepatic brosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis. Br J Haematol, 02824(3) : 2141-5.
Okuda M,Li K,Beard MR,Showalter LA,Scholle F,Lemon SM .2002 .Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology, 30983(2) : 366-75.
Yen YH,Kuo FY,Kee KM,Chang KC,Tsai MC,Hu TH .2018 .APRI and FIB-4 in the evaluation of liver brosis in chronic hepatitis C patients strati ed by AST level. PLoS One, 0199760(6) : .
Oikonomou T,Chrysavgis L,Kiapidou S,Adamantou M,Parastatidou D,Papatheodoridis GV .2023 .Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosisA. nn Gastroenterol, 0800(4) : 442-8.
Kim TH,Um SH,Lee YS,Yim SY,Jung YK,Seo YS .2022 .Determinants of re-compensation in patients with hepatitis B virus-related decompensated cirrhosis starting antiviral therapy. Aliment Pharmacol Ther, 10(1) : 83-96.
0

Citations

0

Downloads

143

Views